BLACK WEEKSViale −15 % · kompleti −10 % · ostalo −5 %s kodoBrezplačna dostava v Nemčiji od 200 €

Ta stran je bila prevedena samodejno in lahko vsebuje napake. Ste materni govorec? Veseli bomo vaših povratnih informacij in popravkov.Pošljite povratne informacije

The Peptide Desk The Peptide Desk
Telmisartan, fotografija izdelka

Laboratorijsko poročilo

PDF
Testirano
Testirano
Telmisartan 40mg × 100 Tabs
Laboratorij
Analiza Białek
Datum
October 2026
Rezultat
39.80 mg per tablet (40 mg label)
Št. naročila
Geslo

Neodvisno testirano, preverljivo z geslom neposredno pri laboratoriju.

Medication

Telmisartan

Medication

Naročilo

Cena na kos - Brezplačna dostava v Nemčiji od 200 € med Black Weeks
  • DHL s sledenjem
  • Diskretna embalaža

4.6 od 5 na Trustpilotu73 ocen

Na prvi pogled

Telmisartan v številkah

Ključni podatki iz našega leksikona. Povlecite točko po krivulji in poglejte, koliko po izračunu ostane po enem odmerku.

Celoten vnos v leksikonu

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~24 hours

Half-life ~24 hours
After 48 hours: 25 %
Hour 2450 %Hour 4825 %Hour 7212.5 %Hour 1203.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

Approximately24hours

Class
Angiotensin II receptor antagonistARB
Use
Blood pressure controlcardiovascular protection
Sizes
40 to 80 mg2 sizes in the shop

Znanje

Vse o Telmisartan

Podrobne informacije bodo kmalu na voljo.

Odmerjanje

Nalaganje podatkov o odmerjanju …

Več v leksikonu

FAQ

Pogosta vprašanja

Viri za vsak odgovor: vnos v leksikonu

Imate še vprašanje?

Pišite nam, naša ekipa vam bo pomagala.

Is telmisartan approved?

Yes. ChEMBL lists telmisartan with phase 4 as the highest phase and first approval in 1998. ClinicalTrials.gov lists 349 trials with telmisartan, as of 26 October 2026.

What did ONTARGET show?

25,620 patients with vascular disease or high-risk diabetes received ramipril, telmisartan or both. After about 56 months the primary outcome was 16.5, 16.7 and 16.3 percent. Telmisartan was equivalent, the combination brought no benefit but more side effects.

And if an ACE inhibitor is not tolerated?

TRANSCEND tested this in 5,926 patients against placebo. The primary outcome was not significantly less common at 15.7 versus 17.0 percent. Cardiovascular death, heart attack or stroke occurred in 13.0 versus 14.8 percent, also not significant after correction.

Why less cough than with ACE inhibitors?

According to ChEMBL telmisartan blocks the AT1 receptor and not the enzyme ACE. In ONTARGET 1.1 percent had cough with telmisartan, 4.2 percent with ramipril. Angioedema occurred in 0.1 versus 0.3 percent.

What was measured in heart failure with weak kidneys?

In a small open trial with 107 patients kidney function worsened less often than with enalapril after 3 months (6.4 versus 22.9 percent). Hospital stays for heart failure were less common (34.1 versus 55.3 percent), there were 5 deaths in each group.

What do the trials on insulin and combinations show?

In 70 patients with diabetes and high blood pressure HOMA-IR fell to 1.79 after 12 weeks instead of 3.45 with other blood pressure drugs. A meta-analysis of 3 trials found stronger blood pressure lowering with amlodipine and better LDL values with rosuvastatin, tolerability was similar.

Sorodno

Sorodni izdelki